Phong Phu Pharmaceutical JSC (HNX:PPP)

Vietnam flag Vietnam · Delayed Price · Currency is VND
21,100
+700 (3.43%)
At close: Jul 14, 2025
28.66%
Market Cap184.80B
Revenue (ttm)141.69B
Net Income (ttm)17.46B
Shares Out8.80M
EPS (ttm)1,988.41
PE Ratio10.56
Forward PEn/a
Dividend1,500.00 (6.76%)
Ex-Dividend DateMar 21, 2025
Volume100
Average Volume1,072
Open21,100
Previous Close20,400
Day's Range21,100 - 21,100
52-Week Range15,700 - 23,100
Beta0.02
RSI51.05
Earnings DateJul 21, 2025

About HNX:PPP

Phong Phu Pharmaceutical Joint Stock Company engages in the production, sale, and distribution of medicines primarily in Vietnam. The company’s medicines are derived from medicinal herbs, pharmaceutical chemicals, and health protection food, that are offered in tablets, film-coated, sugar-coated, soft capsules, granules, powder, and other forms. It offers its products for respiratory, spiritual, anti-inflammatory, anti-allergic, digest, cardiovascular, diabetes, liver function, and osteoarthritis, as well as provides vitamins and minerals. The ... [Read more]

Industry Pharmaceutical Preparations
Founded 2000
Employees 212
Stock Exchange Hanoi Stock Exchange
Ticker Symbol PPP
Full Company Profile

Financial Performance

In 2024, HNX:PPP's revenue was 137.55 billion, a decrease of -9.61% compared to the previous year's 152.17 billion. Earnings were 15.55 billion, a decrease of -14.28%.

Financial Statements

News

There is no news available yet.